Intermediate Clinical Endpoints

Intermediate Clinical Endpoints is a type of clinical outcome measure that serves as a surrogate marker of a disease process, enabling earlier assessment of treatment effects during the accelerated approval of medical therapies by predicting meaningful patient benefits with reasonable likelihood.

129

Publications

11.1K

Citations

945

Authors

456

Institutions

Publications per year

2017–2026

34

Variants

Intermediate Clinical Endpoint

Authors

945

  1. PW
    Patrick W. Serruys

    Erasmus University Rotterdam, Netherlands

    5 publications · 3.5K citations

    5

    h-index

  2. EH
    Eugene H. Blackstone

    Cleveland Clinic, United States

    5 publications · 3.5K citations

    5

    h-index

  3. DE
    Donald E. Cutlip

    Beth Israel Deaconess Medical Center, United States

    5 publications · 3.5K citations

    5

    h-index

  4. SW
    Stephan Windecker

    University Hospital of Bern, Switzerland

    4 publications · 3.4K citations

    4

    h-index

  5. PV
    Pascal Vranckx

    Hartcentrum Hasselt, Belgium

    4 publications · 3.4K citations

    4

    h-index

1–5 of 945

Venues

  1. PubMed

    Repository · 8 publications · 252 citations

    8

    h-index

  2. The Annals of Thoracic Surgery

    ATS · 4 publications · 111 citations

    4

    h-index

  3. European Heart Journal

    4 publications · 2.3K citations

    4

    h-index

  4. Blood

    3 publications · 186 citations

    3

    h-index

  5. Urology

    3 publications · 84 citations

    3

    h-index

1–5